Cellectis Preferred Stock Payments (Quarterly) Analysis

Cellectis SA (CLLS)

4.00 +0.04 (+1.01%) USD | NASDAQ | Feb 24, 14:11

View Preferred Stock Payments (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Stock Payments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Stock Payments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Stock Payments (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	--
Ascendis Pharma A/S	--
Akari Therapeutics Plc	--
Biodexa Pharmaceuticals Plc	--